您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览0

Background Breast cancer patients often use complementary and alternative medicine, but few prospectively collected data on the topic are available specifically for postmenopausal breast cancer patients. A large prospective study was therefore conducted within a noninterventional study in order to identify the characteristics of patients interested in integrative medicine. Methods The EvAluate-TM study is a prospective, multicenter noninterventional study in which treatment with the aromatase inhibitor letrozole was evaluated in postmenopausal women with hormone receptor-positive primary breast cancer. Between 2008 and 2009, 5045 postmenopausal patients were enrolled at 339 certified breast centers in Germany. As part of the data collection process, patients were asked at the baseline about their interest in and information needs relating to integrative medicine. Results Of the 5045 patients recruited, 3411 responded to the questionnaire on integrative medicine and took part in the analysis, 1583 patients expressed an interest in integrative medicine, and 1828 patients declared no interest. Relevant predictors of interest in integrative medicine were age, body mass index, tumor size, previous chemotherapy, and use of concomitant medications for other medical conditions. Interest in integrative medicine declined highly significantly (P < .001) with age (<50 years, 74.1

作者:Carolin C, Hack;Peter A, Fasching;Tanja, Fehm;Johann, de Waal;Mahdi, Rezai;Bernd, Baier;Gerold, Baake;Hans-Christian, Kolberg;Martin, Guggenberger;Mathias, Warm;Nadia, Harbeck;Rachel, Wuerstlein;J?rg-Uwe, Deuker;Peter, Dall;Barbara, Richter;Grischa, Wachsmann;Cosima, Brucker;Jan W, Siebers;Nikos, Fersis;Thomas, Kuhn;Christopher, Wolf;Hans-Walter, Vollert;Georg-Peter, Breitbach;Wolfgang, Janni;Robert, Landthaler;Andreas, Kohls;Daniela, Rezek;Thomas, Noesslet;Gunnar, Fischer;Stefan, Henschen;Thomas, Praetz;Volker, Heyl;Thorsten, Kühn;Thomas, Krauss;Christoph, Thomssen;Andre, Hohn;Hans, Tesch;Christoph, Mundhenke;Alexander, Hein;Claudia, Rauh;Christian M, Bayer;Adib, Jacob;Katja, Schmidt;Erik, Belleville;Peyman, Hadji;Sara Y, Brucker;Diethelm, Wallwiener;Sherko, Kümmel;Matthias W, Beckmann;Daniela, Paepke

来源:Integrative cancer therapies 2016 年

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:0
作者:
Carolin C, Hack;Peter A, Fasching;Tanja, Fehm;Johann, de Waal;Mahdi, Rezai;Bernd, Baier;Gerold, Baake;Hans-Christian, Kolberg;Martin, Guggenberger;Mathias, Warm;Nadia, Harbeck;Rachel, Wuerstlein;J?rg-Uwe, Deuker;Peter, Dall;Barbara, Richter;Grischa, Wachsmann;Cosima, Brucker;Jan W, Siebers;Nikos, Fersis;Thomas, Kuhn;Christopher, Wolf;Hans-Walter, Vollert;Georg-Peter, Breitbach;Wolfgang, Janni;Robert, Landthaler;Andreas, Kohls;Daniela, Rezek;Thomas, Noesslet;Gunnar, Fischer;Stefan, Henschen;Thomas, Praetz;Volker, Heyl;Thorsten, Kühn;Thomas, Krauss;Christoph, Thomssen;Andre, Hohn;Hans, Tesch;Christoph, Mundhenke;Alexander, Hein;Claudia, Rauh;Christian M, Bayer;Adib, Jacob;Katja, Schmidt;Erik, Belleville;Peyman, Hadji;Sara Y, Brucker;Diethelm, Wallwiener;Sherko, Kümmel;Matthias W, Beckmann;Daniela, Paepke
来源:
Integrative cancer therapies 2016 年
标签:
aromatase inhibitor breast cancer complementary and alternative medicine information integrative medicine letrozole oncology therapy management
Background Breast cancer patients often use complementary and alternative medicine, but few prospectively collected data on the topic are available specifically for postmenopausal breast cancer patients. A large prospective study was therefore conducted within a noninterventional study in order to identify the characteristics of patients interested in integrative medicine. Methods The EvAluate-TM study is a prospective, multicenter noninterventional study in which treatment with the aromatase inhibitor letrozole was evaluated in postmenopausal women with hormone receptor-positive primary breast cancer. Between 2008 and 2009, 5045 postmenopausal patients were enrolled at 339 certified breast centers in Germany. As part of the data collection process, patients were asked at the baseline about their interest in and information needs relating to integrative medicine. Results Of the 5045 patients recruited, 3411 responded to the questionnaire on integrative medicine and took part in the analysis, 1583 patients expressed an interest in integrative medicine, and 1828 patients declared no interest. Relevant predictors of interest in integrative medicine were age, body mass index, tumor size, previous chemotherapy, and use of concomitant medications for other medical conditions. Interest in integrative medicine declined highly significantly (P < .001) with age (<50 years, 74.1